ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GOVXW GeoVax Labs Inc

0.0599
-0.0001 (-0.17%)
May 24 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
GeoVax Labs Inc GOVXW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
-0.0001 -0.17% 0.0599 15:02:00
Open Price Low Price High Price Close Price Previous Close
0.0599 0.0599 0.0599 0.0599 0.06
more quote information »

Recent News

Date Time Source Heading
5/24/202415:04EDGAR2Form 8-K - Current report
5/23/202415:07EDGAR2Form 8-K - Current report
5/21/202416:23EDGAR2Form 8-K - Current report
5/21/202411:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/15/202415:03EDGAR2Form 8-K - Current report
5/14/202416:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/14/202416:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/14/202416:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/14/202416:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/14/202415:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
4/04/202411:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
3/28/202408:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
3/12/202408:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
3/06/202408:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
2/29/202415:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
2/22/202408:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
2/19/202408:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
2/13/202408:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
2/06/202408:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
1/29/202408:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
1/08/202408:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
1/04/202408:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
1/03/202408:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
12/27/202308:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
12/19/202308:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
11/30/202315:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
11/29/202308:00GLOBEGeoVax to Participate in Upcoming December Investor Events
11/28/202308:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
11/14/202308:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
11/08/202315:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
10/31/202308:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
10/30/202308:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
10/25/202308:00GLOBEGeoVax to Participate in Upcoming November Investor and..
10/24/202308:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
10/09/202308:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
10/05/202308:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
9/27/202308:00GLOBEGeoVax to Participate in Upcoming October Investor and..
9/26/202308:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
9/20/202308:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
9/19/202308:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
9/12/202308:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
9/11/202308:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
8/31/202308:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
8/28/202308:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
8/10/202308:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
8/09/202315:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
7/26/202308:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
7/24/202308:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
7/20/202308:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
7/10/202308:00GLOBEGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS..

Your Recent History

Delayed Upgrade Clock